为了让您及时了解神经药理学与精神药理学领域的最新见解与关键研究成果，Future Pharmacology精选了一系列热门论文。

本文献清单展示了该关键领域内的重大进展。当前，神经科学与精神病学正面临多重挑战：全球心理健康负担日益加重、神经免疫相互作用错综复杂、神经可塑性机制不断演变，以及临床前模型与临床疗效之间长期存在的转化鸿沟。这些因素正严峻考验着传统的药物研发与治疗管理模式。在此背景下，这一快速发现的时代正催生出全新的研究范式，将神经退行性疾病、双相情感障碍及物质成瘾等领域的研究有机融合。

我们相信，这些发人深省的文章将为您提供新颖的视角，并在神经药理学与精神药理学这一不断演变的领域中，激发您在研究与临床实践方面的深入探索与创新。

1.

The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders

溶血磷脂酸在神经精神与神经退行性疾病中的作用

https://www.mdpi.com/2673-9879/4/1/14

Dedoni, S.; Camoglio, C.; Siddi, C.; Scherma, M.; Fratta, W.; Fadda, P. The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders. Future Pharmacol. 2024, 4, 199–221; https://doi.org/10.3390/futurepharmacol4010014.

2.

Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease

纳米技术驱动的神经退行性疾病治疗创新：聚焦阿尔茨海默病与帕金森病

https://www.mdpi.com/2673-9879/4/2/20

Krsek, A.; Baticic, L. Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease. Future Pharmacol. 2024, 4, 352–379; https://doi.org/10.3390/futurepharmacol4020020.

3.

Future Pharmacotherapy for Bipolar Disorders: Emerging Trends and Personalized Approaches

双相情感障碍的未来药物治疗：新兴趋势与个体化策略

https://www.mdpi.com/2673-9879/5/3/42

Marano, G.; Lisci, F.M.; Boggio, G.; Marzo, E.M.; Abate, F.; Sfratta, G.; Traversi, G.; Mazza, O.; Pola, R.; Sani, G.; Gaetani, E.; Mazza, M. Future Pharmacotherapy for Bipolar Disorders: Emerging Trends and Personalized Approaches. Future Pharmacol. 2025, 5, 42; https://doi.org/10.3390/futurepharmacol5030042.

4.

Nanoparticle-Based Strategies to Enhance Catecholaminergic Drug Delivery for Neuropsychiatric Disorders: Advances, Challenges, and Therapeutic Opportunities

纳米颗粒增强神经精神疾病儿茶酚胺能药物递送的策略：进展、挑战与治疗机遇

https://www.mdpi.com/2673-9879/5/3/51

Cobos-Puc, L.E.; Rodríguez-Salazar, M.d.C.; Silva-Belmares, S.Y.; Aguayo-Morales, H. Nanoparticle-Based Strategies to Enhance Catecholaminergic Drug Delivery for Neuropsychiatric Disorders: Advances, Challenges, and Therapeutic Opportunities. Future Pharmacol. 2025, 5, 51. https://doi.org/10.3390/futurepharmacol5030051.

5.

Beyond One-Size-Fits-All: Personalized Medicine and Future Directions in Sex-Based Psychopharmacological Treatment

超越“一刀切”模式：个体化医疗与基于性别的精神药理学治疗的未来方向

https://www.mdpi.com/2673-9879/4/3/30

Mazza, M.; Lisci, F.M.; Brisi, C.; Traversi, G.; Gaetani, E.; Pola, R.; Marano, G.; Marano, G. Beyond One-Size-Fits-All: Personalized Medicine and Future Directions in Sex-Based Psychopharmacological Treatment. Future Pharmacol. 2024, 4, 541–563; https://doi.org/10.3390/futurepharmacol4030030.

6.

Breaking the Chains: Advances in Substance Addiction Research through Single-Cell Sequencing, Epigenetics, and Epitranscriptomic

打破桎梏：单细胞测序、表观遗传学及表观转录组学在物质成瘾研究中的进展

https://www.mdpi.com/2673-9879/4/1/9

Filoševic Vujnovic, A.; Stankovic Matic, I.; Saftic Martinovic, L; Devic Pavlic, S. Breaking the Chains: Advances in Substance Addiction Research through Single-Cell Sequencing, Epigenetics, and Epitranscriptomic. Future Pharmacol. 2024, 4, 115–138; https://doi.org/10.3390/futurepharmacol4010009.

7.

Perampanel-Induced Psychosis and Psychosis-like Symptoms: A Systematic Review

吡仑帕奈诱发的精神病及类精神病症状：一项系统评价

https://www.mdpi.com/2673-9879/6/1/10

Taslakovic, P.Z.; Milosavljevic, M.N.; Janjic, V.; Stefanovic, S. Perampanel-Induced Psychosis and Psychosis-like Symptoms: A Systematic Review. Future Pharmacol. 2026, 6, 10; https://doi.org/10.3390/futurepharmacol6010010.

8.

Transdiagnostic Pharmacology of Addictions: Current Evidence and Future Perspectives

成瘾的跨诊断药理学：现有证据与未来展望

https://www.mdpi.com/2673-9879/6/2/19

da Silveira, S.P.L.; Aguiar, B.; Ruwel, A.G.; Martins, P.F.; Lewis, D.G.; Moura, H.; Peglow, M.T.; Von Diemen, L.; Gil, A.; Kessler, F.H.P. Transdiagnostic Pharmacology of Addictions: Current Evidence and Future Perspectives. Future Pharmacol. 2026, 6, 19; https://doi.org/10.3390/futurepharmacol6020019.

精选特刊

Transdiagnostic Psychopharmacology: Bridging Mechanisms Across Mental Disorders

投稿截止日期: 30 June 2027

客座编辑：Prof. Dr. Felix Kessler

https://www.mdpi.com/journal/futurepharmacol/special_issues/KX7TY3HMVV

期刊介绍

主编：Prof. Dr. Fabrizio Schifano

University of Hertfordshire, UK

期刊主要发表所有药理学相关的前沿研究成果，主题包括但不限于：临床药理、生化药理、细胞药理、分子药理、神经药理、精神药理、行为药理、药物滥用和成瘾、毒理学、药物遗传学、药物基因组学、药物发现和治疗学等。

2025 Impact Factor：2.7

Time to First Decision：17.7 Days

Acceptance to Publication：5.9 Days